Skip to main content
Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
120.90
+0.20 (0.17%)
Dec 4, 2025, 3:10 PM AST

TADAWUL:4016 Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
2,4182,436----
Enterprise Value
2,4612,496----
Last Close Price
120.90119.61----
PE Ratio
24.8530.51----
Forward PE
22.5124.86----
PS Ratio
5.276.18----
PB Ratio
6.516.62----
P/TBV Ratio
7.767.67----
P/FCF Ratio
28.76100.97----
P/OCF Ratio
23.9869.02----
EV/Sales Ratio
5.366.33----
EV/EBITDA Ratio
20.6925.19----
EV/EBIT Ratio
22.9727.95----
EV/FCF Ratio
29.27103.45----
Debt / Equity Ratio
0.170.180.200.300.330.25
Debt / EBITDA Ratio
0.520.660.731.111.050.72
Debt / FCF Ratio
0.742.710.861.443.445.49
Asset Turnover
0.870.800.760.700.73-
Inventory Turnover
1.561.681.441.371.45-
Quick Ratio
1.741.851.491.361.591.52
Current Ratio
2.652.652.362.222.302.66
Return on Equity (ROE)
27.90%23.67%22.44%21.72%25.52%-
Return on Assets (ROA)
12.64%11.39%10.83%10.10%12.09%-
Return on Capital (ROIC)
16.07%13.91%13.21%12.06%14.23%-
Return on Capital Employed (ROCE)
25.40%22.70%23.40%22.30%25.40%28.20%
Earnings Yield
4.02%3.28%----
FCF Yield
3.48%0.99%----
Dividend Yield
2.07%1.67%----
Payout Ratio
48.29%18.79%54.69%61.14%56.12%49.80%
Total Shareholder Return
2.07%1.67%----
Source: S&P Capital IQ. Standard template. Financial Sources.